Skip to main content
OpenTrials
Completed

NCT Number: NCT04780308

Pediatric Type III Supracondylar Humeral Fracture

The purpose of this study was to compare pin configuration effects on early secondary displacement in the surgical treatment of pediatric supracondylar humeral fractures (SCHF).

Completed

Looking for future studies?

Notify Me

Key information

Age range

Up to 16 year

Sex eligibility

All sexes

Study type

Observational

About this study

The study consisted of 100 (68M, 32F) children who underwent surgery between 2010 and 2013 for Gartland Type 3 (SCHF). The patients divided into five groups according to the top in configurations (crossed 1 lateral 1 medial, crossed 2 lateral 1 medial, crossed 1 lateral 2 medial, 2 lateral divergent, and 3 lateral divergent). The average age at the time of injury was 7.34 (between 2 and 14 years). Bauman angle (BA), Humerocapital angle (HCA), Anterior humeral line (AHL), flexion range, extension range, and Carrying angle (CA) were compared at preoperative, postoperative 1st-day, postoperative last control, and non-operated side. The mean follow-up time 24,96±11,06 with a range of 12-54 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pediatric Gartland Type 3 supracondylar humeral fracture
  • Patients operated between 2010-2013
  • Patients under 16 years old

Exclusion criteria

  • Pathological fractures
  • Conservative treated supracondylar fractures
  • Less than the 1-year follow-up
  • Patients with incomplete postoperative follow-up
  • Patients older than 16 years
  • Pediatric Gartland Type 1 and 2 supracondylar humeral fracture

Treatment and study plan

Pediatric Garthland Type 3 supracondylar humeral fractures fixed by K-wires

Procedure

The effects of the different types of K-wire configuration on Pediatric Gartland Type 3 supracondylar humeral fractures were evaluated. Pediatric Gartland Type 3 supracondylar humeral fractures operated under general anesthesia with open or closed reduction. After reduction checked by fluoroscopy K-wires applied in different configurations.

Primary outcomes

  1. Baumann Angle

    Time frame: postoperative 1. day, 1. month and 12. month

    This angle is formed by the humeral axis and a straight line through the epiphyseal plate of the capitellum. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

  2. Anterior Humeral Line

    Time frame: postoperative 1. day, 1. month and 12. month

    A line drawn down the anterior surface of the humerus should intersect the middle third of the capitellum. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

  3. Humero-Capital Angle

    Time frame: postoperative 1. day, 1. month and 12. month

    On lateral X-ray angle between capitellum and humeral shaft. Preoperative and postoperative angle differences are measured in anteroposterior and lateral X rays. These differences are measured for reduction quality and these parameters shows the success of the surgery.

Sponsors and collaborators

Lead sponsor

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Other Gov

Registry information

Official study title

How Many K Wires do we Need in the Surgical Treatment of Pediatric Type III Supracondylar Humeral Fracture?

Acronym: Fracture

Important dates

Study start
2010
Primary completion
2013
Study completion
2015
First posted
Mar 3, 2021
Registry last updated
Mar 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.